Articles by Shilpa Gupta, MD
The final segment of this roundtable series addresses the future of immunotherapy combinations.
The fifth segment of this roundtable series focuses on the use of circulating tumor DNA (ctDNA) in managing bladder cancer.
In part four of this roundtable, the use of immunotherapy in the adjuvant setting for bladder cancer is discussed.
The third segment of this roundtable series focuses on the latest developments in bladder cancer treatments.
In part two of this roundtable, multidisciplinary approaches to managing MIBC are discussed.
The first segment of this roundtable series focuses on the latest developments in MIBC treatment, including the NIAGARA trial
During the final part of this panel, novel ADCs are explored and analyzed for use in different settings.
During the fourth segment of this panel, novel ADCs including HER3, Nectin-4, and BT8009 are analyzed.
In the third part of this panel, the use of HER2 ADCs in bladder cancer is explored.
In the second segment of this panel, the use of sacituzumab govitecan monotherapy and combinations is discussed.
In the first part of this panel, the use and impact of enfortumab vedotin in the bladder cancer landscape is considered.
The panelists wrap up this peri-operative therapy session with what the envision for the future for sparing bladders.
In this third segment, the panelists discuss bladder-sparing approaches.
The second part of this four-part segment includes conversation about ctDNA in bladder cancer.
The first part of four segments from the panel session on peri-operative therapy in bladder cancer.
View the live recording of the "Will New Antibody Drug Conjugates Cure Bladder Cancer?" session from Uromigos Live 2024.
Peri-Operative Therapy in Urothelial Carcinoma: Live Session From The Uromigos Live & Unplugged 2024
Featuring Tom Powles, MD; Petros Grivas, MD; Shilpa Gupta, MD; Kala Sridhar, MD; and Andrea Apolo, MD. 
Drs. Gupta and Nizam discuss the findings from the patient-reported outcomes in the EV-302 trial for urothelial carcinoma.
Dr. Gupta traces the trajectory of her career and describes her commitment to advancing the field through innovative trials.
Dr. Gupta details some of her latest research and describes the importance of multiple new initiatives in bladder cancer.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.